Guangzhou Virotech Pharmaceutical Co., Ltd.
Guangzhou Virotech Pharmaceutical Co., Ltd.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-09-11 | NCT06046742 | |
| A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-09-10 | NCT06826313 | |
| A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, diffuse midline glioma, H3 K27M-mutant, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-05-15 | NCT07589257 | |
| A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC | hepatocellular carcinoma | Recruiting | Phase 2 / Phase 3 | 2026-05-15 | NCT07589244 | |
| A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-01-02 | NCT07093814 | |
| A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2025-12-30 | NCT06368921 | |
| A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-08-17 | NCT06758544 | |
| A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2025-03-10 | NCT06866977 |